Guangzhou Innogen Pharmaceutical Group Co., Ltd. (02591) released its monthly return for October 2025. The total authorized share capital remains RMB 456,819,349, comprising 420,285,370 H shares listed on the Hong Kong Stock Exchange and 36,533,979 unlisted shares. Both categories of issued shares showed no adjustments during the month, and there were no treasury shares on record.

According to the announcement, the par value per share in both listed and unlisted categories stayed at RMB 1. No share options, warrants, convertibles, or additional agreements for share issuance were reported, and there were no other alterations in issued shares or treasury shares for this period.